I would love to say that if you have ever had a cold sore, you will know how frustrating it can be. They are unattractive and embarrassing, but they are also itchy and uncomfortable. If you are like most people, you will do everything you can to make them leave as quickly as possible. If you are looking for an effective treatment for cold sores, then you might have heard of Abreva. But with a price tag of over $20 per tube, some people wonder why it is so expensive.
Let’s go further and find out some related 8 Reasons to find why Abreva is so expensive?
Reasons that makes Abreva expensive!
The reasons are obvious, Abreva is the only FDA-approved therapy for cold sores. Abreva had to go through FDA testing in order to be approved. The active ingredient in Abreva is patented. Generic versions of the medication can’t be produced by other companies. The company that makes Abreva spends lots of money on advertising. Let’s check out why abreva is so expensive right now, go through the details now.
Recommendation by Doctors
The high cost of Abreva is often due to the fact it is a prescription medication.
If you want to get your hands on this product, you will need to visit a doctor and get a prescription. It increases the cost of the product. It also makes it more difficult to get the product.
Abreva is a prescription medication, which means that it has to go through more scrutiny before being allowed to hit the market.
The high price tag of this product is the result of all of these factors. Cold sores are caused by herpes simplex virus (HSV). Abreva is one of the most effective cold sore treatments on the market.
DA-Approved (Treatment for Cold Sores)
It’s very professional and expensive too. It’s the only FDA-approved treatment for cold sores.
Cold sores are a symptom of cold sore, an infection caused by the herpes simplex virus. There are many over the counter treatments, but none of them have been proven to be effective in clinical trials. Abreva, on the other hand, has been shown to shorten the duration of cold sores by an average of 4 days.
In addition, it can also help to reduce the pain and swelling associated with cold sores. Because people who suffer from frequent cold sores are more likely to pay more for this product than the average person, it will be profitable for this company to make this product.
Rigorous Testing by FDA
Company have to pay more in order to get FDA (Food and Drug Administration) approval because the process itself is too expensive that makes it expensive one.
Drugs aren’t tested in an artificial environment. In fact, only about 10% of medicines are tested on animals, so their efficacy and safety can’t be judged until
Once a new drug is approved by the FDA, it must be studied in a huge array of clinical trials and studies to make sure it is safe and effective. Cold sores (Herpes Simplex) are a painful, uncomfortable, and embarrassing disease.
Abreva Is Not Available in Generic Form
Abreva is not available in a generic form, which is one of the reasons why it is so expensive. Other pharmaceutical companies are not able to make their own version of the medication because it is still under patent protection. For people who need this type of treatment, Abreva remains the only option. Patients have to pay for a prescription from their doctor, in addition to the high cost of the drug.
This can add up to a significant expense for many people. In some cases, insurance plans may be able to help offset the cost of Abreva, but many patients are left with a large portion of the bill out-of-pocket. Some people are looking for ways to save money on Abreva, because of the high cost of the medication. It is important to remember that this is a prescription medication, and it should only be used under the guidance of a healthcare professional. Before starting any new treatment, it is advisable to speak with your doctor to see if it is the right option for you.
Active Ingredient (Docosanol)
Docosanol is the only topical agent approved by the FDA for the treatment of open wounds (with or without infection) but the active ingredient makes it more expensive.The healing process of cold sores can be sped up with the help of docosanol. Companies have to pay a licensing fee to the patent holder in order to create a cream with this ingredient.
The fee is passed on to the consumer in the form of higher prices. There are other cold sore creams on the market that do not contain docosanol, but they are not as effective at speeding up the healing process. Many people are willing to pay a high price for Abreva in order to get relief from their cold sores more quickly.
Effective in Treating Cold Sores
One of the main reasons for the high price of Abreva is its effectiveness. Abreva is one of the best drugs for treating cold sores. It was shown to speed up healing time in clinical trials. The severity of symptoms can be reduced. Abreva can be used to help people who suffer from cold sore episodes. It’s easy to see why Abreva has a high price tag.
Abreva may be more expensive due to the company’s advertising budget. One of the world’s largest pharmaceutical companies is Glaxosmithkline. It can spend millions of dollars on advertising. Money is spent on TV commercials, online ads, and print ads. This advertising may not be directly responsible for the high cost of Abreva, but it does contribute to the company’s marketing expenses. Consumers are likely to pay higher prices because of these expenses. The high cost of Abreva is likely to be caused by the marketing efforts of GSK.
It’s all about the quality of the product that makes it the market leader, so it is dependant upon the demand of the Abreva as well, since the demand is huge so the price remains unchanged, I like the dominance in the market.
Some enormous reasons make it expensive, however, it is worth it to buy this cream if you have any kind of infection, the product is trustworthy. There are a number of factors that contribute to the high cost of this medication, from the cost of its active ingredient to the company’s advertising budget. The most important factor is it’s effectiveness. It is possible for Abreva to be a lifesaver for people who suffer from frequent cold sore episodes.